| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/27/2008 | WO2008036239A2 Use of lxr agonists for the treatment of osteoarthritis |
| 03/27/2008 | WO2008035823A1 Cell death inhibitor |
| 03/27/2008 | WO2008035816A1 Promoter of hard tissue regeneration |
| 03/27/2008 | WO2008035756A1 Anti-angiogenic composition comprising extract having anti-angiogenic activity and lecithin |
| 03/27/2008 | WO2008034974A1 2-ARYL-6-PHENYLIMIDAZO[1,2-α]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 03/27/2008 | WO2008034781A1 Cysteine protease inhibitor salt |
| 03/27/2008 | WO2008034328A1 New use of ginsenoside compound-k in manufacturing medicaments |
| 03/27/2008 | WO2008012563A3 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 03/27/2008 | WO2008002671A3 Metalloprotease inhibitors |
| 03/27/2008 | WO2007142818A3 Use of a soluble morphogenic protein complex for treating cartilage defects |
| 03/27/2008 | WO2007132179A3 Therapeutics comprising pyridinium derivatives |
| 03/27/2008 | US20080077372 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 03/27/2008 | US20080076834 administering a combination of erythritol and glycerin; moisterizers; psoriasis and keratoderma; |
| 03/27/2008 | US20080076813 Benzene, Pyridine, and Pyridazine Derivatives |
| 03/27/2008 | US20080076804 Methods for inhibiting and breaking age complex formation |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080076795 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators |
| 03/27/2008 | US20080076763 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol; 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(2S)-2-morpholinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol for treating cancer and arthritis |
| 03/27/2008 | US20080076757 Medicine for treating gastrointestinal disorder including irritable bowel syndrome |
| 03/27/2008 | US20080076743 osteoarthritis; administered once daily for at least about two weeks |
| 03/27/2008 | US20080076739 anticancer, antitumor; Phosphoric acid mono-(2-(3-{2-[5-(3,5-dimethyl-1H-pyrrol-2-ylmethylene)-4-methoxy-5H-pyrrol-2-yl]-indol-1-yl]-1,1-dimethyl-3-oxo-propyl)-3-methylphenyl]ester |
| 03/27/2008 | US20080076715 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 03/27/2008 | US20080076714 oral or mucosal administration for treating immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease and other inflammatory diseases; drug delivery method |
| 03/27/2008 | US20080076711 Therapeutic agents for osteopenia |
| 03/27/2008 | US20080075782 Comprising a stabilizing polyol and a bioactive agent, wherein the composition provides quick release of the bioactive agent after administration; inhalation through the mouth; drug delivery; osteoporosis treatment |
| 03/27/2008 | US20080075751 Method for IN VIVO, EX VIVO and IN VITRO rapair and regeneration of cartilage and collagen and bone remodeling |
| 03/27/2008 | US20080075728 Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation |
| 03/27/2008 | US20080075727 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075703 using a mixture of cells including connective tissue cells transfected or transduced with genes encoding transforming growth factors or bone morphogenic proteins, used for regenerating cartilage and treatment of osteoarthritis; somatic cell gene therapy; tissue-targeted therapy |
| 03/27/2008 | DE202007014139U1 Mittel zur äußerlichen und/oder innerlichen Anwendung Means for external and / or internal use |
| 03/27/2008 | DE102006044448A1 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 03/27/2008 | DE102006042742A1 Nano-Vehikel für den transkutanen Transport, diese enthaltende Zubereitungen und deren Anwendung Nano vehicle for transcutaneous delivery, compositions containing them and their use |
| 03/27/2008 | CA2662848A1 2-aryl-6-phenylimidazo[1,2-.alpha.]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/27/2008 | CA2646911A1 2- substituted-1alpha, 25-dihydroxy-19,26,27-trinor vitamin d analogs and uses thereof |
| 03/27/2008 | CA2646909A1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 03/27/2008 | CA2645185A1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof |
| 03/26/2008 | EP1903113A1 Multifunctional protease inhibitors and their use in treatment of disease |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903038A1 N-(1-hetaryl-piperidin-4-yl)-(het)arylamide as EP2 receptor modulators |
| 03/26/2008 | EP1902714A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 03/26/2008 | EP1902318A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis |
| 03/26/2008 | EP1902031A1 Cathepsin cysteine protease inhibitors |
| 03/26/2008 | EP1901765A1 Intralesional treatment of psoriasis |
| 03/26/2008 | EP1663294B1 Treatment of fibrotic disease |
| 03/26/2008 | EP1455790B1 Use of pyridine-2,4-dicarboxylic acid diamides and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition |
| 03/26/2008 | EP1248847B1 Irak-4: compositions and methods of use |
| 03/26/2008 | CN101151239A Novel biaromatic compounds, inhibitors of the P2X7-receptor |
| 03/26/2008 | CN101151048A Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 03/26/2008 | CN101151045A Methods for suppressing neovascularization using EphrinB2 |
| 03/26/2008 | CN101148642A Probiotic/non-probiotic combinations |
| 03/26/2008 | CN101148638A Marrow-strengthening cold-dispersing nourishing wine |
| 03/26/2008 | CN101147802A Composition for treating knee-joint cross ligament damage |
| 03/26/2008 | CN101147800A Casein phosphopeptide cyclodextrin inclusion compound without bitter and its preparation method |
| 03/26/2008 | CN101147795A Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia |
| 03/26/2008 | CN101147774A Traditional Chinese medicinal composition for treating fracture and soft tissue bruise |
| 03/26/2008 | CN101147770A Orally-administered medicine for treating periomethritis |
| 03/26/2008 | CN101147762A Externally-applied medicine for treating arthritis |
| 03/26/2008 | CN101147754A Compound effervescence preparation containing pureraria root extraction |
| 03/26/2008 | CN101147743A Application of ginsenoside Compound-K in pharmaceutical |
| 03/26/2008 | CN100377465C Intelligent serial cell charger and charging circuit block |
| 03/26/2008 | CN100376595C Promoter for the production of hyaluronic acid containing ginsenoside compound K |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376579C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and use in treating |
| 03/26/2008 | CN100376573C 1,3-dihydroimidazole fused-ring compound |
| 03/26/2008 | CN100376571C 6-substituted pyrido-pyrimidines |
| 03/26/2008 | CN100376567C Qinazoline derivatives as VEGF inhibitors |
| 03/26/2008 | CN100376557C Quinoline derivatives as ligands for the neuropeptide y receptor |
| 03/26/2008 | CN100376530C Vitamin D analogues |
| 03/26/2008 | CN100376270C Externally applied medicine ointment for treating Yin-icterus and bone Bi-syndrome and its preparation process |
| 03/26/2008 | CN100376267C Pharmaceutical formulation consisting of plant extract with calcium coating |
| 03/26/2008 | CN100376254C Preparation for bone injury and preparation process |
| 03/26/2008 | CN100376245C Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 03/26/2008 | CN100376242C 2-aryl-propionic acid and medicine composition containing same |
| 03/25/2008 | US7348433 3-[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-quinolin-2(1H)-ones or 5--[p-(phenoxy, phenylthio, phenylsulfinyl, or phenylsulfonyl)benzyl]-pyrrolo[3,2,1-IJ]quinolin-4(4H)-ones; type E antagonists; analgesics, antipyretics, antiinflammatory agents; side effect reduction |
| 03/25/2008 | US7348431 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/25/2008 | US7348426 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 03/25/2008 | US7348400 α-conotoxin peptides with analgesic properties |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348341 Chemical compounds |
| 03/25/2008 | US7348339 2-(4-amino-furazan-3-yl)-1-ethyl-N-[(2R)-2-morpholinylmethyl]-1H-imidazo[4,5-c]pyridine-7-carboxamide; Mitogen- and Stress-Activated Protein (MSK) and Rho (guanosine triphosphate) 1 or 2 kinase inhibitor; neurodegenerative diaeases; antiinflammatory, anticarcinogenic, antiviral and antibacterial agent |
| 03/25/2008 | US7348336 Inhibitors of IkB kinase (I Kappa B Kinase); 1-acetyl-7-bromo- beta -carboline; antiinflammatory and anticarcinogenic agent; asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, infections, and cardiac infarct |
| 03/25/2008 | US7348335 Compositions useful as inhibitors of JAK and other protein kinases |
| 03/25/2008 | US7348333 Treating bone disorder caused by osteoclasts, tumor growth and tumor metastasis, prophylaxis of cardiovascular disorders, nephropathies or retinopathies |
| 03/25/2008 | US7348327 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 03/25/2008 | US7348313 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis |
| 03/25/2008 | US7348162 Nucleotide sequences coding polypeptides for use in the treatment and prevention of hematopoietic disorders, osteoporosis, osteogenesis, paget's disease, periodontal disease, hypercalcemia, cancer, cachexia, and |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348017 such as 2-[Benzyl[(4-methoxyphenyl)sulfonyl]amino]-N-(3-thioxo-3H-1,2,4-dithiazol-5-yl)acetoamide; cosmetics; antiaging agents |
| 03/25/2008 | US7347999 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 03/25/2008 | US7347995 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients |
| 03/25/2008 | CA2370446C Pharmaceutical compounds |
| 03/25/2008 | CA2277273C Integrin antagonists |
| 03/20/2008 | WO2008034008A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033999A2 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | WO2008033798A2 A pyrrolopyrazin as syk-kinase inhibitor |
| 03/20/2008 | WO2008032764A1 Fused heterocyclic derivative |
| 03/20/2008 | WO2008032678A1 Adhesive preparation |
| 03/20/2008 | WO2008031572A1 Novel nutraceutical and pharmaceutical compositions and use thereof for the treatment, co-treatment or prevention of cartilage degradation or cartilage damage in joints |